Subscribe“Cardiometabolic conditions, which encompass type 2 diabetes, lesser degrees of glucose intolerance and the whole spectrum of cardiovascular diseases, have become major challenges in many parts of the developed and developing world.
Obesity is now considered by the World Health Organization (WHO) to be an even bigger health problem than cigarette smoking and it is clear that overweight and obesity, particularly abdominal/central obesity, 'drives' cardiometabolic diseases.
When I was a medical student, we were told that there were 50 million people with diabetes worldwide. This number has now reached 200 million and is projected to climb to 370 million by 2025. This is truly a problem of epidemic proportions.
A recent headline in 'The Independent' suggested that, for the first time in 200 years, longevity might actually decrease with time in the UK and elsewhere because of diabetes and other co-morbidities associated with weight gain.
It is indeed possible that the reduction in cardiovascular deaths seen in recent years in the UK and elsewhere could reverse, especially if the obesity trends in our childhood population continue. In addition, cardiovascular rates are now starting to climb rapidly in developing countries."
Professor Tony Barnett, Professor of Medicine, University of Birmingham and Consultant Physician, Birmingham Heartlands & Solihull NHS Trust (Teaching)
Cardiometabolic Risk and Weight Management (formerly Obesity in Practice) focuses on the serious co-morbidities associated with weight gain. It emphasises cardiometabolic disease and its management as well as providing advice on weight management issues.
Cardiometabolic Risk and Weight Management is a quarterly journal aimed at healthcare professionals who are working to minimise the impact of cardiometabolic risk factors.
Sponsored by an unrestricted education grant from sanofi-aventis, Cardiometabolic Risk and Weight Management promotes best practice to reduce vascular and metabolic morbidity and mortality through effective weight management.
Although primarily intended for the primary care multidisciplinary team, Cardiometabolic Risk and Weight Management will also be of interest to those working in secondary care with an interest in cardiometabolic risk and weight management.
The journal provides accurate and up-to-date referenced articles on topical areas of clinical and academic interest, presented in an accessible, easy to read format. All articles are peer reviewed and have a high clinical value.
Editorial Board
The editorial board of Cardiometabolic Risk and Weight Management brings together approximately six key experts who are actively involved in the management of cardiometabolic risk and weight management. The board is lead by an editor, who is responsible for ensuring the journal presents an independent and balanced view and decides on the content with the help of the board..
Editor
A. H. Barnett
Professor of Medicine, University of Birmingham, and Consultant Physician, Birmingham Heartlands & Solihull NHS Hospital Trust (Teaching)
Editorial board members
Iain Broom
Research Professor in Clinical Biochemistry & Metabolic Medicine, Robert Gordon University and NHS Grampian, Aberdeen
Sudhesh Kumar
Professor of Medicine, Diabetes and Metabolism, University of Warwick Medical School, Coventry
Dympna Pearson
Consultant Dietitian, Quorn, Leicestershire
Peter Stott
General Practitioner, Tadworth, Surrey
John Wilding
Professor of Medicine, Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool
Further information, including abstracts of the contents of each issue, can be obtained by visiting the MEP Ltd website - www.mepltd.co.uk or contacting MEP directly.